shire map
Select a
Location

Shire Global

Investor Relations

Our Strategy

We focus on researching, developing and marketing innovative medicines that have the potential to transform the lives of people around the world with rare and other specialized conditions. Our strategy is to grow value for all our stakeholders – focusing and excelling in everything we do to meet the current and future needs of patients. We are on a dynamic journey characterized by high growth, ongoing innovation and leadership in the areas in which we choose to compete.

Where we are heading

Transforming lives
Our purpose is to enable people with life altering conditions to lead better lives.

A leading global biotech
We aspire to be a leading, global biotech delivering innovative medicines to patients with rare diseases and other specialty conditions.


Product sales; Percent CAGR

2013: five billion dollars in-line. 2020: Seven billion dollars in-line, three billion dollars existing pipeline, ten billion-plus dollars upside.

*$5bn represents sales from continuing
operations.

1 Products included in pipeline as of February 2014


By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.

By following this link you will be leaving the global Shire.com website for another Shire website. Please note that this website may not be appropriate for all audiences.

RETURN CONTINUE